Market closed

Alcon/$ALC

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Alcon

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Ticker

$ALC
Sector
Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Headquarters

Geneva, Switzerland

Employees

25,000
Website
www.alcon.com

Alcon Metrics

BasicAdvanced
$41B
35.36
$2.34
0.73
$0.16
0.19%

$41B

0.73

$99.64

$74.30

750K

$0.16

2.573

1.529

23.063

23.956

11.20%

6.38%

2.55%

5.59%

35.365

4.187

1.75

10.03

33.585

0.19%

0.19%

5.25%

156.61%

6.49%

51.75%

What the Analysts think about Alcon

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Alcon stock.

Alcon Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Alcon Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Alcon News

AllArticlesVideos
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

Business Wire·2 weeks ago
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

Business Wire·2 weeks ago
Alcon: Q3, Slight Guidance Cut Is Not Something Structural

Alcon: Q3, Slight Guidance Cut Is Not Something Structural

Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ALC

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Alcon stock?

Alcon (ALC) has a market cap of $41B as of January 15, 2025.

What is the P/E ratio for Alcon stock?

The price to earnings (P/E) ratio for Alcon (ALC) stock is 35.36 as of January 15, 2025.

Does Alcon stock pay dividends?

Yes, the Alcon (ALC) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.156 and the yield is 0.19%. Alcon has a payout ratio of 11.2% on a trailing twelve-month basis.

When is the next Alcon dividend payment date?

The next Alcon (ALC) dividend payment date is unconfirmed.

What is the beta indicator for Alcon?

Alcon (ALC) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.